A test measuring proteins in spinal fluid may help support the diagnosis of MS, especially in patients whose disease is harder to diagnose.
Hosted on MSN
Protein ratio in cerebrospinal fluid outperforms traditional biomarkers in predicting Alzheimer's cognitive decline
A potential new biomarker for predicting future cognitive resilience versus decline among people with early Alzheimer's disease is described in Nature Medicine. This protein signature may improve the ...
Researchers have identified a set of 22 proteins that distinguish multiple sclerosis from other inflammatory diseases.
Summary: Women make up nearly two-thirds of Alzheimer’s patients, and researcher may have just discovered a massive reason why. A new study found that when the protein alpha-synuclein (typically ...
Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results